nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—Transcriptional regulation of pluripotent stem cells—PRDM14—testicular cancer	0.209	0.405	CbGpPWpGaD
Niclosamide—CYP2C9—Ifosfamide—testicular cancer	0.194	0.496	CbGbCtD
Niclosamide—CYP1A2—Etoposide—testicular cancer	0.103	0.263	CbGbCtD
Niclosamide—CYP2C9—Cisplatin—testicular cancer	0.0945	0.241	CbGbCtD
Niclosamide—STAT3—embryo—testicular cancer	0.0299	0.325	CbGeAlD
Niclosamide—STAT3—Signaling events mediated by Stem cell factor receptor (c-Kit)—KITLG—testicular cancer	0.0204	0.0396	CbGpPWpGaD
Niclosamide—STAT3—gonad—testicular cancer	0.0203	0.221	CbGeAlD
Niclosamide—STAT3—Kit receptor signaling pathway—KITLG—testicular cancer	0.0182	0.0352	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR mutants—FGFR3—testicular cancer	0.0168	0.0325	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PRDM14—testicular cancer	0.0167	0.0323	CbGpPWpGaD
Niclosamide—STAT3—female gonad—testicular cancer	0.0165	0.179	CbGeAlD
Niclosamide—STAT3—testis—testicular cancer	0.0146	0.159	CbGeAlD
Niclosamide—STAT3—FGF signaling pathway—FGFR3—testicular cancer	0.0145	0.0281	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by Stem cell factor receptor (c-Kit)—KIT—testicular cancer	0.0139	0.027	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—H2AFZ—testicular cancer	0.0125	0.0241	CbGpPWpGaD
Niclosamide—STAT3—Kit receptor signaling pathway—KIT—testicular cancer	0.0124	0.024	CbGpPWpGaD
Niclosamide—STAT3—lymph node—testicular cancer	0.0106	0.115	CbGeAlD
Niclosamide—STAT3—AGE/RAGE pathway—MMP2—testicular cancer	0.01	0.0195	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—KITLG—testicular cancer	0.00905	0.0175	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—KITLG—testicular cancer	0.00814	0.0158	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—H2AFZ—testicular cancer	0.00789	0.0153	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—KITLG—testicular cancer	0.00755	0.0146	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—KITLG—testicular cancer	0.00738	0.0143	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—FGFR3—testicular cancer	0.00673	0.013	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.00669	0.013	CbGpPWpGaD
Niclosamide—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00627	0.0122	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—KIT—testicular cancer	0.00618	0.012	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—FGFR3—testicular cancer	0.00605	0.0117	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—H2AFZ—testicular cancer	0.00596	0.0115	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.00573	0.0111	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—FGFR3—testicular cancer	0.00561	0.0109	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—KIT—testicular cancer	0.00556	0.0108	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—FGFR3—testicular cancer	0.00549	0.0106	CbGpPWpGaD
Niclosamide—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00536	0.0104	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—KIT—testicular cancer	0.00515	0.00998	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—KITLG—testicular cancer	0.00514	0.00996	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—KIT—testicular cancer	0.00504	0.00976	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.00497	0.00963	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.00456	0.00884	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—FGFR3—testicular cancer	0.00382	0.0074	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—INSL3—testicular cancer	0.00375	0.00727	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—KIT—testicular cancer	0.00351	0.0068	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	0.00341	0.00661	CbGpPWpGaD
Niclosamide—STAT3—Immune System—BCL10—testicular cancer	0.00283	0.00549	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—HPGDS—testicular cancer	0.00233	0.00452	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP2—testicular cancer	0.00201	0.00389	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—HPGDS—testicular cancer	0.00199	0.00386	CbGpPWpGaD
Niclosamide—STAT3—Disease—H2AFZ—testicular cancer	0.00171	0.00332	CbGpPWpGaD
Niclosamide—STAT3—Immune System—KITLG—testicular cancer	0.00171	0.00331	CbGpPWpGaD
Niclosamide—STAT3—Disease—KITLG—testicular cancer	0.00158	0.00306	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FGFR3—testicular cancer	0.00127	0.00246	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—H2AFZ—testicular cancer	0.0012	0.00233	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—STK11—testicular cancer	0.00119	0.00231	CbGpPWpGaD
Niclosamide—STAT3—Disease—FGFR3—testicular cancer	0.00117	0.00227	CbGpPWpGaD
Niclosamide—STAT3—Immune System—KIT—testicular cancer	0.00117	0.00226	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KITLG—testicular cancer	0.0011	0.00214	CbGpPWpGaD
Niclosamide—STAT3—Disease—KIT—testicular cancer	0.00108	0.00209	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000896	0.00174	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FGFR3—testicular cancer	0.000821	0.00159	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000766	0.00148	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KIT—testicular cancer	0.000754	0.00146	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HPGDS—testicular cancer	0.000399	0.000773	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HPGDS—testicular cancer	0.000341	0.000661	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—STK11—testicular cancer	0.00029	0.000562	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—STK11—testicular cancer	0.000248	0.00048	CbGpPWpGaD
